981 followers
RT @AdisJournals: Read our AdisInsight Report on Lumateperone following its recent FDA approval, briefly reviewing the pharmacological prop…
RT @AdisJournals: Read our AdisInsight Report on Lumateperone following its recent FDA approval, briefly reviewing the pharmacological prop…
Read our AdisInsight Report on Lumateperone following its recent FDA approval, briefly reviewing the pharmacological properties, clinical efficacy and tolerability of the agent. Read the article here: https://t.co/gxZoVrvqUC #Schizophrenia https://t.co/p
New article: Lumateperone: First Approval. https://t.co/kJnBPhZ8H4 #alzheimers #neurology